| Name | Title | Contact Details |
|---|
Reliable Controls manufactures simple, flexible, sustainable building automation solutions that balance comfort and efficiency while reducing greenhouse gas emissions in buildings around the world. Our goal to help others achieve their goals begins by listening. We hear the World Green Building Councils call to businesses, organizations, cities, states, and regions to reach net-zero operation by 2050. The next 30 years are critical. In the world of building automation systems, that means you want products that are built responsibly and built to last. Reliable Controls technology is backward compatible, better by design, and supported by responsible recycling. Install our controllers now, and they will thrive for decades. Thats a sustainable return on investment. This dedication to multigenerational success is unique to our brand and reflects our pledge to sustainability. Its with purpose that we refer to our lineup of controllers or sensors as a family; each generation adds value, and nothing is rendered obsolete. We also take great pride in creating a healthy, sustainable working environment for our employees—as evidenced in our Canadas Greenest Employer Award honors in 2020.
Tech Observer is a global Contract Research Organization (CRO) founded in 2005, with its headquarters in Paramus, New Jersey, and additional offices in New Delhi, Mumbai, and Singapore. The company specializes in clinical development support for the pharmaceutical, biotechnology, and medical device industries, extending its reach through local partners across the Asia-Pacific region. The company offers a comprehensive range of services that encompass the entire clinical research process. These include managing clinical trials, clinical data management, biostatistics and SAS programming, medical writing, post-marketing clinical studies, and staffing services. Tech Observer is ISO 9001:2008 and ISO 14155:2011 certified, demonstrating its commitment to quality and regulatory compliance. With a workforce of around 400 professionals, the company serves over 50 clients in more than 30 countries, focusing on various therapeutic areas such as oncology, cardiology, and infectious diseases. Tech Observer also emphasizes innovation with solutions like its AI-driven clinical trial risk tool, MyRBQM, and promotes diversity and professional growth within its team.